Synthesis of Novel 2-(Het)arylpyrrolidine Derivatives and Evaluation of Their Anticancer and Anti-Biofilm Activity. 2019

Andrey Smolobochkin, and Almir Gazizov, and Marina Sazykina, and Nurgali Akylbekov, and Elena Chugunova, and Ivan Sazykin, and Anastasiya Gildebrant, and Julia Voronina, and Alexander Burilov, and Shorena Karchava, and Maria Klimova, and Alexandra Voloshina, and Anastasia Sapunova, and Elena Klimanova, and Tatyana Sashenkova, and Ugulzhan Allayarova, and Anastasiya Balakina, and Denis Mishchenko
Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center of RAS, Arbuzov str., 8, Kazan 420088, Russia.

A library of novel 2-(het)arylpyrrolidine-1-carboxamides were obtained via a modular approach based on the intramolecular cyclization/Mannich-type reaction of N-(4,4-diethoxybutyl)ureas. Their anti-cancer activities both in vitro and in vivo were tested. The in vitro activity of some compounds towards M-Hela tumor cell lines was twice that of the reference drug tamoxifen, whereas cytotoxicity towards normal Chang liver cell did not exceed the tamoxifen toxicity. In vivo studies showed that the number of surviving animals on day 60 of observation was up to 83% and increased life span (ILS) was up to 447%. Additionally, some pyrrolidine-1-carboxamides possessing a benzofuroxan moiety obtained were found to effectively suppress bacterial biofilm growth. Thus, these compounds are promising candidates for further development both as anti-cancer and anti-bacterial agents.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Andrey Smolobochkin, and Almir Gazizov, and Marina Sazykina, and Nurgali Akylbekov, and Elena Chugunova, and Ivan Sazykin, and Anastasiya Gildebrant, and Julia Voronina, and Alexander Burilov, and Shorena Karchava, and Maria Klimova, and Alexandra Voloshina, and Anastasia Sapunova, and Elena Klimanova, and Tatyana Sashenkova, and Ugulzhan Allayarova, and Anastasiya Balakina, and Denis Mishchenko
February 2012, European journal of medicinal chemistry,
Andrey Smolobochkin, and Almir Gazizov, and Marina Sazykina, and Nurgali Akylbekov, and Elena Chugunova, and Ivan Sazykin, and Anastasiya Gildebrant, and Julia Voronina, and Alexander Burilov, and Shorena Karchava, and Maria Klimova, and Alexandra Voloshina, and Anastasia Sapunova, and Elena Klimanova, and Tatyana Sashenkova, and Ugulzhan Allayarova, and Anastasiya Balakina, and Denis Mishchenko
January 2017, Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents,
Andrey Smolobochkin, and Almir Gazizov, and Marina Sazykina, and Nurgali Akylbekov, and Elena Chugunova, and Ivan Sazykin, and Anastasiya Gildebrant, and Julia Voronina, and Alexander Burilov, and Shorena Karchava, and Maria Klimova, and Alexandra Voloshina, and Anastasia Sapunova, and Elena Klimanova, and Tatyana Sashenkova, and Ugulzhan Allayarova, and Anastasiya Balakina, and Denis Mishchenko
February 2010, European journal of medicinal chemistry,
Andrey Smolobochkin, and Almir Gazizov, and Marina Sazykina, and Nurgali Akylbekov, and Elena Chugunova, and Ivan Sazykin, and Anastasiya Gildebrant, and Julia Voronina, and Alexander Burilov, and Shorena Karchava, and Maria Klimova, and Alexandra Voloshina, and Anastasia Sapunova, and Elena Klimanova, and Tatyana Sashenkova, and Ugulzhan Allayarova, and Anastasiya Balakina, and Denis Mishchenko
September 2019, European journal of medicinal chemistry,
Andrey Smolobochkin, and Almir Gazizov, and Marina Sazykina, and Nurgali Akylbekov, and Elena Chugunova, and Ivan Sazykin, and Anastasiya Gildebrant, and Julia Voronina, and Alexander Burilov, and Shorena Karchava, and Maria Klimova, and Alexandra Voloshina, and Anastasia Sapunova, and Elena Klimanova, and Tatyana Sashenkova, and Ugulzhan Allayarova, and Anastasiya Balakina, and Denis Mishchenko
January 2019, Frontiers in oncology,
Andrey Smolobochkin, and Almir Gazizov, and Marina Sazykina, and Nurgali Akylbekov, and Elena Chugunova, and Ivan Sazykin, and Anastasiya Gildebrant, and Julia Voronina, and Alexander Burilov, and Shorena Karchava, and Maria Klimova, and Alexandra Voloshina, and Anastasia Sapunova, and Elena Klimanova, and Tatyana Sashenkova, and Ugulzhan Allayarova, and Anastasiya Balakina, and Denis Mishchenko
November 2020, Bioorganic chemistry,
Andrey Smolobochkin, and Almir Gazizov, and Marina Sazykina, and Nurgali Akylbekov, and Elena Chugunova, and Ivan Sazykin, and Anastasiya Gildebrant, and Julia Voronina, and Alexander Burilov, and Shorena Karchava, and Maria Klimova, and Alexandra Voloshina, and Anastasia Sapunova, and Elena Klimanova, and Tatyana Sashenkova, and Ugulzhan Allayarova, and Anastasiya Balakina, and Denis Mishchenko
June 2020, Bioorganic & medicinal chemistry,
Andrey Smolobochkin, and Almir Gazizov, and Marina Sazykina, and Nurgali Akylbekov, and Elena Chugunova, and Ivan Sazykin, and Anastasiya Gildebrant, and Julia Voronina, and Alexander Burilov, and Shorena Karchava, and Maria Klimova, and Alexandra Voloshina, and Anastasia Sapunova, and Elena Klimanova, and Tatyana Sashenkova, and Ugulzhan Allayarova, and Anastasiya Balakina, and Denis Mishchenko
September 2014, ACS medicinal chemistry letters,
Andrey Smolobochkin, and Almir Gazizov, and Marina Sazykina, and Nurgali Akylbekov, and Elena Chugunova, and Ivan Sazykin, and Anastasiya Gildebrant, and Julia Voronina, and Alexander Burilov, and Shorena Karchava, and Maria Klimova, and Alexandra Voloshina, and Anastasia Sapunova, and Elena Klimanova, and Tatyana Sashenkova, and Ugulzhan Allayarova, and Anastasiya Balakina, and Denis Mishchenko
May 2019, Archiv der Pharmazie,
Andrey Smolobochkin, and Almir Gazizov, and Marina Sazykina, and Nurgali Akylbekov, and Elena Chugunova, and Ivan Sazykin, and Anastasiya Gildebrant, and Julia Voronina, and Alexander Burilov, and Shorena Karchava, and Maria Klimova, and Alexandra Voloshina, and Anastasia Sapunova, and Elena Klimanova, and Tatyana Sashenkova, and Ugulzhan Allayarova, and Anastasiya Balakina, and Denis Mishchenko
November 2013, European journal of medicinal chemistry,
Copied contents to your clipboard!